These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17983443)

  • 1. Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis.
    Han S; Chong V; Murray T; McDonagh T; Hunter J; Poon FW; Gray HW; Neilly JB
    Eur J Haematol; 2007 Dec; 79(6):494-500. PubMed ID: 17983443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-aprotinin scintigraphy in amyloidosis.
    Schaadt BK; Hendel HW; Gimsing P; Jønsson V; Pedersen H; Hesse B
    J Nucl Med; 2003 Feb; 44(2):177-83. PubMed ID: 12571206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of
    Awaya T; Minamimoto R; Iwama K; Kubota S; Hotta M; Hirai R; Yamamoto M; Okazaki O; Hara H; Hiroi Y; Hiroe M; Moroi M
    J Nucl Cardiol; 2020 Aug; 27(4):1145-1153. PubMed ID: 31591695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung amyloid nodule detected by 99mTc-aprotinin scintigraphy.
    Ishii S; Kubota K; Minamimoto R; Kouketu R; Morooka M; Kawai S; Takeda Y; Kobayashi N; Sugiyama H
    Ann Nucl Med; 2012 Jul; 26(6):522-6. PubMed ID: 22610387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin.
    Aprile C; Marinone G; Saponaro R; Bonino C; Merlini G
    Eur J Nucl Med; 1995 Dec; 22(12):1393-401. PubMed ID: 8586084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging in systemic amyloidosis.
    Sachchithanantham S; Wechalekar AD
    Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
    Gertz MA; Brown ML; Hauser MF; Kyle RA
    Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear imaging in cardiac amyloidosis.
    Glaudemans AW; Slart RH; Zeebregts CJ; Veltman NC; Tio RA; Hazenberg BP; Dierckx RA
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):702-14. PubMed ID: 19156411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
    Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging.
    Minamimoto R; Kubota K; Ishii K; Morooka M; Okasaki M; Miyata Y; Nakajima K; Sato T; Igari T; Hirai R; Okazaki O
    Am J Nucl Med Mol Imaging; 2013; 3(3):261-71. PubMed ID: 23638337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of
    Minamimoto R; Awaya T; Iwama K; Hotta M; Nakajima K; Hirai R; Okazaki O; Hiroi Y
    J Nucl Cardiol; 2020 Feb; 27(1):202-209. PubMed ID: 29589208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon.
    Cappelli F; Gallini C; Costanzo EN; Tutino F; Ciaccio A; Vaggelli L; Bartolini S; Morini S; Martone R; Angelotti P; Frusconi S; Di Mario C; Perfetto F
    Int J Cardiol; 2018 Mar; 254():346-350. PubMed ID: 29407121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aprotinin scintigraphy in amyloidosis].
    Haraldsen A; Eskild-Jensen A; Frøkiaer J
    Ugeskr Laeger; 2009 May; 171(22):1837-9. PubMed ID: 19486611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
    Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
    Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated cardiac amyloidosis. Utility of bone seeking tracers scintigraphy in differentiating the subtype of amyloid: A case report.
    Bourogianni O; Papadaki E; Foukarakis E; Koukouraki S
    J Nucl Cardiol; 2019 Feb; 26(1):337-341. PubMed ID: 29476454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft-tissue uptake of 99mTc-diphosphonate in systemic AL amyloidosis.
    Janssen S; van Rijswijk MH; Piers DA; de Jong GM
    Eur J Nucl Med; 1984; 9(12):538-41. PubMed ID: 6441712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic functional hyposplenism in amyloidosis.
    Powsner RA; Simms RW; Chudnovsky A; Lee VW; Skinner M
    J Nucl Med; 1998 Feb; 39(2):221-3. PubMed ID: 9476921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy.
    Gallini C; Tutino F; Martone R; Ciaccio A; Costanzo EN; Taborchi G; Morini S; Bartolini S; Farsetti S; Di Mario C; Perfetto F; Cappelli F
    J Nucl Cardiol; 2021 Feb; 28(1):90-99. PubMed ID: 30767162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.